5 Pharmaceuticals preparations for the treatment of psychogenic depression, endogenous depression, involutional depression, epilepsy, Parkinson's disease myoclonia, choreic movements, down's syndrome, phenylketonuria, migraine and vasomotor cephalalgia, sleep disorders, central nervous system disorders and dietary supplements containing tripytophane